Kyle Mikson
Stock Analyst at Canaccord Genuity
(1.92)
# 3,178
Out of 4,983 analysts
88
Total ratings
37.5%
Success rate
-7.71%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QSI Quantum-Si incorporated | Maintains: Hold | $1 | $1.28 | -21.57% | 4 | Sep 9, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $37 | $21.69 | +70.59% | 5 | Sep 9, 2025 | |
| QTRX Quanterix | Downgrades: Hold | $12 → $5 | $5.23 | -4.31% | 7 | Aug 11, 2025 | |
| ILMN Illumina | Maintains: Hold | $99 → $105 | $100.19 | +4.80% | 12 | Aug 1, 2025 | |
| XGN Exagen | Maintains: Buy | $8 → $11 | $9.17 | +20.02% | 4 | Jul 30, 2025 | |
| GRAL GRAIL | Maintains: Buy | $32 → $43 | $38.30 | +12.27% | 2 | May 14, 2025 | |
| BDSX Biodesix | Maintains: Buy | $50 → $30 | $7.01 | +327.96% | 4 | May 14, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $18 → $15 | $13.05 | +14.94% | 8 | May 12, 2025 | |
| GH Guardant Health | Maintains: Buy | $60 → $65 | $54.38 | +19.53% | 7 | May 1, 2025 | |
| RGEN Repligen | Maintains: Hold | $170 → $150 | $117.00 | +28.21% | 3 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.20 | +150.00% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $195 | $173.76 | +12.22% | 8 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.05 | +187.08% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $75 | $53.15 | +41.11% | 9 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.64 | +214.96% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $0.40 | +12,105.41% | 1 | Mar 30, 2021 |
Quantum-Si incorporated
Sep 9, 2025
Maintains: Hold
Price Target: $1
Current: $1.28
Upside: -21.57%
Castle Biosciences
Sep 9, 2025
Maintains: Buy
Price Target: $37
Current: $21.69
Upside: +70.59%
Quanterix
Aug 11, 2025
Downgrades: Hold
Price Target: $12 → $5
Current: $5.23
Upside: -4.31%
Illumina
Aug 1, 2025
Maintains: Hold
Price Target: $99 → $105
Current: $100.19
Upside: +4.80%
Exagen
Jul 30, 2025
Maintains: Buy
Price Target: $8 → $11
Current: $9.17
Upside: +20.02%
GRAIL
May 14, 2025
Maintains: Buy
Price Target: $32 → $43
Current: $38.30
Upside: +12.27%
Biodesix
May 14, 2025
Maintains: Buy
Price Target: $50 → $30
Current: $7.01
Upside: +327.96%
10x Genomics
May 12, 2025
Maintains: Buy
Price Target: $18 → $15
Current: $13.05
Upside: +14.94%
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $60 → $65
Current: $54.38
Upside: +19.53%
Repligen
Apr 16, 2025
Maintains: Hold
Price Target: $170 → $150
Current: $117.00
Upside: +28.21%
Apr 10, 2025
Maintains: Buy
Price Target: $3
Current: $1.20
Upside: +150.00%
Feb 28, 2025
Maintains: Buy
Price Target: $180 → $195
Current: $173.76
Upside: +12.22%
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.05
Upside: +187.08%
Nov 6, 2024
Maintains: Buy
Price Target: $95 → $75
Current: $53.15
Upside: +41.11%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.64
Upside: +214.96%
Mar 30, 2021
Initiates: Overweight
Price Target: $49
Current: $0.40
Upside: +12,105.41%